• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4830413)   Today's Articles (5247)
For: Lue B, Nielsen FS, Magnussen T, Schou HM, Kristensen K, Jacobsen LO, Müllertz A. Using biorelevant dissolution to obtain IVIVC of solid dosage forms containing a poorly-soluble model compound. Eur J Pharm Biopharm 2008;69:648-57. [PMID: 18280122 DOI: 10.1016/j.ejpb.2007.12.013] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2006] [Revised: 12/17/2007] [Accepted: 12/17/2007] [Indexed: 11/22/2022]
Number Cited by Other Article(s)
1
Abdel-Haleem LM, Ramadan NK, El-Rahman MKA, Galal MM. A Screen-Printed Potentiometric Sensor for Stability Indicating Assay and Real-Time Monitoring of Trospium Chloride Dissolution Profile in its Pharmaceutical Dosage Form. JOURNAL OF THE ELECTROCHEMICAL SOCIETY 2023;170:087506. [DOI: 10.1149/1945-7111/ace8c3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/02/2023]
2
Recent Advances in Dissolution Testing and Their Use to Improve In Vitro–In Vivo Correlations in Oral Drug Formulations. J Pharm Innov 2021. [DOI: 10.1007/s12247-021-09565-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
3
Preparation of Hot-Melt Extruded Dosage Form for Enhancing Drugs Absorption Based on Computational Simulation. Pharmaceutics 2020;12:pharmaceutics12080757. [PMID: 32796665 PMCID: PMC7463902 DOI: 10.3390/pharmaceutics12080757] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2020] [Revised: 08/07/2020] [Accepted: 08/08/2020] [Indexed: 11/16/2022]  Open
4
Taha NF, Emam MF, Emara LH. A novel combination of Soluplus®/Poloxamer for Meloxicam solid dispersions via hot melt extrusion for rapid onset of action. Part 2: comparative bioavailability and IVIVC. Drug Dev Ind Pharm 2020;46:1362-1372. [DOI: 10.1080/03639045.2020.1791164] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
5
Cheng X, Gao J, Li J, Cheng G, Zou M, Piao H. In Vitro-In Vivo Correlation for Solid Dispersion of a Poorly Water-Soluble Drug Efonidipine Hydrochloride. AAPS PharmSciTech 2020;21:160. [PMID: 32476084 DOI: 10.1208/s12249-020-01685-1] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2020] [Accepted: 04/11/2020] [Indexed: 12/11/2022]  Open
6
Development of in vitro - in vivo correlations for newly optimized Nimesulide formulations. PLoS One 2018;13:e0203123. [PMID: 30169547 PMCID: PMC6118371 DOI: 10.1371/journal.pone.0203123] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2018] [Accepted: 08/15/2018] [Indexed: 12/02/2022]  Open
7
Kaur N, Narang A, Bansal AK. Use of biorelevant dissolution and PBPK modeling to predict oral drug absorption. Eur J Pharm Biopharm 2018;129:222-246. [DOI: 10.1016/j.ejpb.2018.05.024] [Citation(s) in RCA: 42] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2017] [Revised: 04/16/2018] [Accepted: 05/21/2018] [Indexed: 11/29/2022]
8
González-García I, García-Arieta A, Merino-Sanjuan M, Mangas-Sanjuan V, Bermejo M. Defining level A IVIVC dissolution specifications based on individual in vitro dissolution profiles of a controlled release formulation. Eur J Pharm Sci 2018;119:200-207. [PMID: 29680456 DOI: 10.1016/j.ejps.2018.04.025] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2018] [Revised: 04/10/2018] [Accepted: 04/18/2018] [Indexed: 11/26/2022]
9
Puppolo MM, Hughey JR, Dillon T, Storey D, Jansen-Varnum S. Biomimetic Dissolution: A Tool to Predict Amorphous Solid Dispersion Performance. AAPS PharmSciTech 2017;18:2841-2853. [PMID: 28560506 DOI: 10.1208/s12249-017-0783-4] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2017] [Accepted: 04/13/2017] [Indexed: 01/15/2023]  Open
10
Joyce P, Yasmin R, Bhatt A, Boyd BJ, Pham A, Prestidge CA. Comparison across Three Hybrid Lipid-Based Drug Delivery Systems for Improving the Oral Absorption of the Poorly Water-Soluble Weak Base Cinnarizine. Mol Pharm 2017;14:4008-4018. [DOI: 10.1021/acs.molpharmaceut.7b00676] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
11
B. Shekhawat P, B. Pokharkar V. Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles. Acta Pharm Sin B 2017;7:260-280. [PMID: 28540164 PMCID: PMC5430883 DOI: 10.1016/j.apsb.2016.09.005] [Citation(s) in RCA: 100] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2016] [Revised: 09/06/2016] [Accepted: 09/21/2016] [Indexed: 11/10/2022]  Open
12
Evaluation of different in vitro dissolution tests based on level A in vitro–in vivo correlations for fenofibrate self-emulsifying lipid-based formulations. Eur J Pharm Biopharm 2017;112:18-29. [DOI: 10.1016/j.ejpb.2016.10.030] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2016] [Revised: 09/13/2016] [Accepted: 10/28/2016] [Indexed: 11/21/2022]
13
Pestieau A, Krier F, Brouwers A, Streel B, Evrard B. Selection of a discriminant and biorelevant in vitro dissolution test for the development of fenofibrate self-emulsifying lipid-based formulations. Eur J Pharm Sci 2016;92:212-9. [PMID: 27169683 DOI: 10.1016/j.ejps.2016.04.038] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2016] [Revised: 04/26/2016] [Accepted: 04/28/2016] [Indexed: 12/13/2022]
14
Yang B, Wu C, Ji B, Wu M, He Z, Shang L, Sun J. Virtual population pharmacokinetic using physiologically based pharmacokinetic model for evaluating bioequivalence of oral lacidipine formulations in dogs. Asian J Pharm Sci 2016;12:98-104. [PMID: 32104318 PMCID: PMC7032150 DOI: 10.1016/j.ajps.2016.03.003] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2016] [Revised: 03/11/2016] [Accepted: 03/14/2016] [Indexed: 11/29/2022]  Open
15
Effect of food intake and co-administration of placebo self-nanoemulsifying drug delivery systems on the absorption of cinnarizine in healthy human volunteers. Eur J Pharm Sci 2016;84:77-82. [PMID: 26775868 DOI: 10.1016/j.ejps.2016.01.011] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2015] [Revised: 12/30/2015] [Accepted: 01/12/2016] [Indexed: 01/04/2023]
16
González-García I, Mangas-Sanjuán V, Merino-Sanjuán M, Bermejo M. In vitro–in vivocorrelations: general concepts, methodologies and regulatory applications. Drug Dev Ind Pharm 2015;41:1935-47. [DOI: 10.3109/03639045.2015.1054833] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
17
Wu C, Kou L, Ma P, Gao L, Li B, Li R, Luo C, Shentu J, He Z, Sun J. Interspecies prediction of oral pharmacokinetics of different lacidipine formulations from dogs to human: physiologically based pharmacokinetic modelling combined with biorelevant dissolution. RSC Adv 2015. [DOI: 10.1039/c4ra16017g] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]  Open
18
Yang B, Wu C, Ji B, Ai X, Kuang X, Wu M, Sun M, Luo C, He Z, Sun J. The biorelevant concentration of Tween 80 solution is a simple alternative medium to simulated fasted state intestinal fluid. RSC Adv 2015. [DOI: 10.1039/c5ra17674c] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]  Open
19
Scott JS, Bowker SS, Brocklehurst KJ, Brown HS, Clarke DS, Easter A, Ertan A, Goldberg K, Hudson JA, Kavanagh S, Laber D, Leach AG, MacFaul PA, Martin EA, McKerrecher D, Schofield P, Svensson PH, Teague J. Circumventing Seizure Activity in a Series of G Protein Coupled Receptor 119 (GPR119) Agonists. J Med Chem 2014;57:8984-98. [DOI: 10.1021/jm5011012] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
20
Micelle dynamic simulation and physicochemical characterization of biorelevant media to reflect gastrointestinal environment in fasted and fed states. Eur J Pharm Biopharm 2014;88:565-73. [DOI: 10.1016/j.ejpb.2014.05.020] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2013] [Revised: 04/17/2014] [Accepted: 05/24/2014] [Indexed: 11/19/2022]
21
Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS). Eur J Pharm Sci 2014;57:164-72. [DOI: 10.1016/j.ejps.2013.11.003] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2013] [Revised: 10/04/2013] [Accepted: 11/05/2013] [Indexed: 12/26/2022]
22
Yaro P, He X, Liu W, Xun M, Ma Y, Li Z, Shi X. In vitro–in vivocorrelations for three different commercial immediate-release indapamide tablets. Drug Dev Ind Pharm 2013;40:1670-6. [DOI: 10.3109/03639045.2013.842577] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
23
Understanding Biorelevant Drug Release from a Novel Thermoplastic Capsule by Considering Microstructural Formulation Changes During Hydration. Pharm Res 2013;31:194-203. [DOI: 10.1007/s11095-013-1152-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2013] [Accepted: 07/16/2013] [Indexed: 11/30/2022]
24
Garbacz G, Klein S. Dissolution testing of oral modified-release dosage forms. J Pharm Pharmacol 2012;64:944-68. [DOI: 10.1111/j.2042-7158.2012.01477.x] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
25
Xu C, Zou M, Wang Y, Liu Y, Yan J, Wu Y, Cheng G. Discriminatory dissolution method for quality control measurements of carbamazepine immediate release tablets based on in vitro--in vivo investigations. Drug Dev Ind Pharm 2011;38:679-88. [PMID: 21988132 DOI: 10.3109/03639045.2011.621433] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
26
Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs. Eur J Pharm Biopharm 2011;78:531-8. [DOI: 10.1016/j.ejpb.2011.02.007] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2009] [Revised: 01/26/2011] [Accepted: 02/09/2011] [Indexed: 11/22/2022]
27
Prajapati ST, Patel AN, Patel CN. Formulation and evaluation of controlled-release tablet of zolpidem tartrate by melt granulation technique. ISRN PHARMACEUTICS 2011;2011:208394. [PMID: 22389845 PMCID: PMC3263716 DOI: 10.5402/2011/208394] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/01/2011] [Accepted: 05/02/2011] [Indexed: 11/23/2022]
28
Shen DM, Lin S, Parmee ER. A survey of small molecule glucagon receptor antagonists from recent patents (2006 – 2010). Expert Opin Ther Pat 2011;21:1211-40. [DOI: 10.1517/13543776.2011.587001] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
29
Kleberg K, Jacobsen J, Müllertz A. Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies. J Pharm Pharmacol 2011;62:1656-68. [PMID: 21039549 DOI: 10.1111/j.2042-7158.2010.01023.x] [Citation(s) in RCA: 105] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
30
Di Maio S, Carrier RL. Gastrointestinal contents in fasted state and post-lipid ingestion: In vivo measurements and in vitro models for studying oral drug delivery. J Control Release 2011;151:110-22. [DOI: 10.1016/j.jconrel.2010.11.034] [Citation(s) in RCA: 56] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2010] [Accepted: 11/29/2010] [Indexed: 10/18/2022]
31
Lalic M, Pilipovic A, Golocorbin-Kon S, Gebauer-Bukurov K, Bozic K, Mikov M, Cvejic J. Comparison of dissolution profiles and serum concentrations of two lamotrigine tablet formulations. Drugs R D 2011;11:53-60. [PMID: 21410295 PMCID: PMC3585764 DOI: 10.2165/11588260-000000000-00000] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]  Open
32
Novel extended-release formulation of lovastatin by one-step melt granulation: In vitro and in vivo evaluation. Eur J Pharm Biopharm 2011;77:306-12. [DOI: 10.1016/j.ejpb.2010.11.024] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2010] [Revised: 11/21/2010] [Accepted: 11/30/2010] [Indexed: 11/20/2022]
33
Scheubel E, Adamy L, Hoffart V, Cardot JM. Selection of the most suitable dissolution method for an extended release formulation based on IVIVC level A obtained on cynomolgus monkey. Drug Dev Ind Pharm 2011;36:1320-9. [PMID: 20849348 DOI: 10.3109/03639041003801877] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
34
Zaki NM, Artursson P, Bergström CAS. A modified physiological BCS for prediction of intestinal absorption in drug discovery. Mol Pharm 2010;7:1478-87. [PMID: 20734997 DOI: 10.1021/mp100124f] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
35
McAllister M. Dynamic Dissolution: A Step Closer to Predictive Dissolution Testing? Mol Pharm 2010;7:1374-87. [DOI: 10.1021/mp1001203] [Citation(s) in RCA: 102] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
36
Tan A, Simovic S, Davey AK, Rades T, Boyd BJ, Prestidge CA. Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems. Mol Pharm 2010;7:522-32. [PMID: 20063867 DOI: 10.1021/mp9002442] [Citation(s) in RCA: 75] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
37
Multivariate Data Analysis of Factors Affecting the In Vitro Dissolution Rate and the Apparent Solubility for a Model Basic Drug Substance in Aqueous Media. Pharm Res 2010;27:1309-17. [DOI: 10.1007/s11095-010-0111-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2009] [Accepted: 03/01/2010] [Indexed: 10/19/2022]
38
Jantratid E, De Maio V, Ronda E, Mattavelli V, Vertzoni M, Dressman JB. Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form. Eur J Pharm Sci 2009;37:434-41. [PMID: 19491035 DOI: 10.1016/j.ejps.2009.03.015] [Citation(s) in RCA: 88] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2009] [Revised: 03/23/2009] [Accepted: 03/27/2009] [Indexed: 10/20/2022]
39
Gray V, Kelly G, Xia M, Butler C, Thomas S, Mayock S. The science of USP 1 and 2 dissolution: present challenges and future relevance. Pharm Res 2009;26:1289-302. [PMID: 19165579 DOI: 10.1007/s11095-008-9822-x] [Citation(s) in RCA: 73] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2008] [Accepted: 12/24/2008] [Indexed: 12/01/2022]
40
Tan A, Simovic S, Davey AK, Rades T, Prestidge CA. Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs. J Control Release 2008;134:62-70. [PMID: 19013488 DOI: 10.1016/j.jconrel.2008.10.014] [Citation(s) in RCA: 129] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2008] [Revised: 09/30/2008] [Accepted: 10/16/2008] [Indexed: 11/30/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA